摘要
目的探讨前列安栓联合热淋清治疗尿道炎后慢性非细菌性前列腺炎（CNP）的临床效果。方法对150例CNP患者，随机分为二组：观察组80例使用前列安栓纳肛，并用热淋清口服；对照组70例单用前列安栓纳肛。分别于4～8周作症状评分和前列腺液（EPS）中WBC计数观察。结果观察组总有效率为85%。NIH-CPSI评分为（9．0±1．0），WBC计数（5．0±0．7）个／HP。而对照组总有救率为56％，NIH-CPSI评分（17．0±0．2），WBC计数（11.0±0．4）个／HP。二组NIH-CPSI评分与WBC计数比较差异均有统计学意义（P〈0.001）；二组CNP总有效率比较差异有统计学意义（P〈0．05）。结论前列安栓联合热淋清对尿道炎后CNP的疗效优于单用前列安栓，该方法值得推广使用。
Objective To explore the efficacy of QianLieanshua combined relinqing in treatment of post-urethritis non bacteria prostatitisc（CNP）. Methods 150 patients were randomly divided into two groups, Qianlieanshua was used locally and ReLinqing was administrated in 80 trials, while Qianlieanshua was used locally in 70 controls. All patients were evaluated with NIH - CPSI scores and WBC counts in EPS, at the end of the 4-8 weeks. Results The total effective rate were 85% in trial group and 56% in control group, There was statistically significant difference between the two groups （P〈0.05）. The NIH - CPSI scores and WBC counts in EPS were（9.0±1.0） and （5.0±0.7）/HP in trial group, （17.0±0.2） and （1.0±0.4）/HP in control group, there were significant difference between the two groups （P 〈 0.001）. Conclusion The therapy combining Qianlieanshua with relinqing in the treatment of post - urethritis CNP has a better efficiency than using Qianlieanshua only and is valuable to he applied.
出处
《中国煤炭工业医学杂志》
2006年第2期124-125,共2页
Chinese Journal of Coal Industry Medicine
关键词
前列腺炎
尿道炎
前列安栓
热淋清
联合治疗
prostatitis
urethritis
qianlieanshua
relinqing
combined therapy
